Experiment 1072291

Details

PropertyValue
Pharmacology
Administration routeIV
OrganismCatharanthus roseus (APOCYNACEAE)
CitationKELSEN,DP: BAINS,M: CVITKOVIC,E: GOLBEY,R:. (1979). VINDESINE IN THE TREATMENT OF ESOPHAGEAL CARCINOMA:A PHASE II STUDY.. 63()
Amount utilized
Compound isolated
DiseaseA PHASE II CLINICAL STUDY IN 26 PATIENTS WITH SQUAMOUS CELL CARCINOMA OF THE ESOPHAGUS DOSING WAS ONCE WEEKLY FOR 7 DOSES AND THEN BIWEEKLY UNTIL DISEASE PROGRESSION,OR UNTIL TOXICITY BECAME SEVERE ENOUGH TO WARRANT ITS DISCONTINUANCE MAJOR TOXIC EFFECTS WERE PERIPHERAL NEUROPATHY(50%),LEUKOPENIA(8%),FEVER AND MYALGIAS(26%) AND ALOPECIA(40%) SEVERE CONSTIPATION OR ILEUS WAS NOT ENCOUNTERED-NAUSEA AND VOMITING WERE NOT PROMINENT COMPLAINTS
Dose amount3.0 MG
Number2
Qualitative resultACTIVE
AnimalHUMAN ADULT
Per unitSQ M BODY SURFACE
Dose expressionDOSE
GenderGIVEN TO BOTH SEXES